发明名称 Co-administration of steroids and zoledronic acid to prevent and treat osteoarthritis
摘要 A combination therapy for treating osteoarthritis is disclosed. The combination therapy includes the co-administration of a steroid and Zoledronic Acid. The coadministration of a steroid decreases the production of cytokines, and, therefore, decreases the pro-inflammatory effects of Zoledronic Acid. The co-administration of Zoledronic Acid with steroids treats osteoarthritis, and helps to prevent the onset of osteoarthritis in patients at risk for osteoarthritis.
申请公布号 US8859530(B2) 申请公布日期 2014.10.14
申请号 US201414202950 申请日期 2014.03.10
申请人 Voltarra Pharmaceuticals, Inc. 发明人 Desai Ketan
分类号 A61K31/66;A61K31/12;A61K31/675;A61K31/573;A61K45/06 主分类号 A61K31/66
代理机构 Hultquist, PLLC 代理人 Hultquist, PLLC ;Bradin David
主权项 1. A method for treating osteoarthritis in a patient in need thereof, the method comprising intravenous administration to the patient a combination of prednisolone or a pharmaceutically acceptable salt thereof and Zoledronic acid or a pharmaceutically acceptable salt thereof in a single infusion.
地址 Bethlehem PA US